Cadre (CDRE) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Q3 2024 net sales were $109.4M, down from $125.1M in Q3 2023, mainly due to cybersecurity incidents disrupting operations, while nine-month net sales rose to $391.6M, driven by acquisitions and higher demand for armor and duty gear.
Net income for Q3 2024 was $3.7M ($0.09/share), a significant decrease year-over-year; nine-month net income was $23.2M ($0.58/share), reflecting lower productivity and higher acquisition expenses.
Adjusted EBITDA for Q3 2024 was $13.5M (12.4% margin), down from $23.7M (19.0%) in Q3 2023; nine-month Adjusted EBITDA was $66.3M (16.9% margin), supported by recent acquisitions.
Orders backlog reached a record $167.2M as of September 30, 2024, up $40.6M from year-end, reflecting acquisition contributions and higher demand.
Continued focus on M&A opportunities, with recent acquisitions contributing to growth and a robust pipeline for further expansion.
Financial highlights
Gross profit margin for Q3 2024 was 36.6%, down from 42.8% in Q3 2023, impacted by lower productivity and acquisition-related amortization.
Product segment Q3 2024 net sales: $96.5M; Distribution segment: $17.8M, both down year-over-year due to cybersecurity disruptions.
Cash and cash equivalents were $93.0M at quarter-end, up from $87.7M at year-end; net cash from operations was $8.1M for the nine months, down from $46.3M prior year.
Net debt at quarter-end was $115.1M, with total debt at $208.1M, reflecting acquisition financing.
Capital expenditures for 2024 projected at $6M–$8M.
Outlook and guidance
Full-year 2024 guidance revised: net sales expected between $560M–$571M and Adjusted EBITDA between $101M–$107M.
Q4 is expected to be a record quarter, driven by pent-up backlog and inventory built in Q3.
Management expects the impact of the cybersecurity incidents to be temporary, with operations resumed and additional countermeasures implemented.
Sufficient liquidity is anticipated for at least the next 12 months, with cash on hand, operating cash flow, and available credit facilities.
Underlying business expected to return to historical growth rates in 2025, with 3% growth in military/law enforcement and 4–6% in nuclear.
Latest events from Cadre
- Strong FY2025 results and disciplined M&A fuel growth, with FY2026 sales guidance up to $758M.CDRE
Investor presentation23 Mar 2026 - Record EBITDA and net income growth in 2025, with double-digit 2026 outlook and higher dividend.CDRE
Q4 202511 Mar 2026 - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 20253 Feb 2026 - Apex armor and robotics launches showcase innovation and global expansion focus.CDRE
Investor Update1 Feb 2026 - Q2 net sales up 19% to $144.3M, adjusted EBITDA margin 19.6%, 2024 guidance unchanged post-cyber event.CDRE
Q2 20241 Feb 2026 - Stable demand, innovation, and operational focus drive growth and margin expansion.CDRE
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Strong market positions and strategic acquisitions drive growth in public safety and nuclear sectors.CDRE
CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference14 Jan 2026 - Strong Q3 2025 results and strategic acquisitions drive growth in safety and nuclear markets.CDRE
Investor presentation14 Jan 2026 - £75M acquisition doubles global nuclear scale and expands safety, robotics, and medicine reach.CDRE
M&A Announcement10 Jan 2026